Oklahoma

In late December, 2018, the National Academy for State Health Policy (NASHP) hosted a webinar exploring Oklahoma Medicaid agency’s use of innovative alternative payment models (APMs) through contracts negotiated with drug manufacturers, which link supplemental rebates to patient outcomes. The webinar, Medicaid Alternative Payment Models for Prescription Drugs: Do They Add Value for States?, featured […]

On the heels of Oklahoma’s first-in-the-nation, value-based purchasing deal to improve adherence to an antipsychotic drug, the state’s Medicaid agency just signed its second value-based contract for a prescription drug used to treat serious bacterial skin infections. While several private insurers have initiated value-based contracting, which links payments to a drug’s effectiveness and outcome, Oklahoma […]

Oklahoma uses focus groups to identify ways to improve treatment guidelines, communication, and medication monitoring for foster care youth enrolled in Medicaid. May is National Foster Care Month and for the fourth consecutive year the number of children in foster care nationwide has climbed, fueled in part by the opioid epidemic, according to the Adoption and […]

As states pursue a wide range of legislation to address rising drug costs, four more states have joined Utah and Vermont to introduce bills to import prescription drugs from Canada through a state-run, wholesale operation. This market-based approach to providing more affordable medicines from Canada, where prescription drugs cost on average 30 percent less than […]

The National Academy for State Health Policy (NASHP) designed this toolkit to support states interested in developing a value-based alternative payment methodology (APM) for federally qualified health centers (FQHCs). The following section on measuring performance discusses key considerations and promising strategies based on lessons learned from states during NASHP’s Value-Based Payment Reform Academy. Types of […]

The National Academy for State Health Policy (NASHP) has awarded $300,000 in grants to Colorado, Delaware, and Oklahoma to help the states develop innovative policy solutions to tackle high prescription drug prices. With the support from the Laura and John Arnold Foundation, the funding enables states to explore promising policy approaches to control rapidly escalating […]

Improving birth outcomes, including reducing infant mortality, is a priority for state Medicaid agencies that finance nearly half of all births each year. Three states have proven to be creative and effective laboratories in developing initiatives that use Medicaid payment and delivery reform strategies to lower costs, improve access to postpartum care, reward high-quality care, […]

State Medicaid agencies have generally found it challenging to include federally qualified health centers (FQHCs) in value-based purchasing initiatives because of a federal law passed in 2000 that regulates how state Medicaid programs pay FQHCs for the care they provide. State Medicaid agencies are required to reimburse FQHCs through the Prospective Payment System (PPS), a […]

State Medicaid agencies, which fund half of all births in the United States, are increasingly looking for ways to improve birth outcomes and maternal health while reducing costs by improving medical care and avoiding medically unnecessary cesarean sections. Two case studies from Wisconsin and Oklahoma show how these states successfully improved health care access and quality by […]